Impact of Ninjin'yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice.

Ninjin’yoeito aging frailty gait klotho-hypomorphic mice muscle atrophy survival telomere

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2022
Historique:
received: 20 06 2022
accepted: 03 10 2022
entrez: 10 11 2022
pubmed: 11 11 2022
medline: 11 11 2022
Statut: epublish

Résumé

With the recent aging of society, the prevention of frailty has become an important issue because people desire both a long and healthy lifespan. Klotho-hypomorphic (kl/kl) mice are known to show phenotypes of premature aging. Ninjin'yoeito (NYT) is a traditional Japanese Kampo medicine used to treat patients with vulnerable constitution, fatigue or physical exhaustion caused by aging and illness. Recent studies have reported the potential efficacy of NYT against frailty. We therefore evaluated the effect of NYT on the gait function, activity, the histopathological status of organs and survival using kl/kl mice as a model of aging-related frailty. Two sets of 28-day-old male kl/kl mice were assigned to the vehicle (non-treated; NT), 3% or 5% NYT dietary groups. One set of groups (NT, n = 18; 3% NYT, n = 11; 5% NYT, n = 11) was subjected to the analysis of free walking, rotarod, and spontaneous activity tests at approximately 58 days old. Thereafter, we measured triceps surae muscles weight and myofiber cross-sectional area (CSA), and quantified its telomere content. In addition, we evaluated bone strength and performed histopathological examinations of organs. Survival was measured in the second set of groups (NT, 3% NYT and 5% NYT group, n = 8 each). In the walking test, several indicators such as gait velocity were improved in the NYT 3% group. Similar results were obtained for the latency to fall in the rotarod test and spontaneous motor activity. Triceps muscle mass, CSA and its telomere content were significantly improved in the NYT 3% group. Bone density, pulmonary alveolus destruction and testicular atrophy were also significantly improved in the NYT 3% group. Survival rate and body weight were both significantly improved in the NYT3% group compared with those in the NT group. Continuous administration of NYT from the early stage of aging improved not only gait performance, but also the survival in the aging-related frailty model. This effect may be associated with the improvements in aging-related organ changes such as muscle atrophy. Intervention with NYT against the progression of frailty may contribute to a longer, healthier life span among the elderly individuals.

Identifiants

pubmed: 36353482
doi: 10.3389/fphar.2022.973897
pii: 973897
pmc: PMC9637981
doi:

Types de publication

Journal Article

Langues

eng

Pagination

973897

Informations de copyright

Copyright © 2022 Amitani, Chiba, Amitani, Michihara, Takemoto, Han, Fujita, Takahashi and Inui.

Déclaration de conflit d'intérêts

Authors HA and AI are affiliated with the Pharmacological Department of Herbal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences. The Pharmacological Department of Herbal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences is a joint research department with Kracie Pharma, Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Front Aging Neurosci. 2016 Feb 03;8:12
pubmed: 26869921
Aging Dis. 2011 Oct;2(5):437-43
pubmed: 22396892
Annu Rev Nutr. 2002;22:309-23
pubmed: 12055348
Mol Psychiatry. 2016 Nov;21(11):1613-1623
pubmed: 26830139
Vitam Horm. 2016;101:85-118
pubmed: 27125739
Am Heart J. 2001 Mar;141(3):334-41
pubmed: 11231428
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
Sci Rep. 2014 Aug 01;4:5847
pubmed: 25080854
Front Physiol. 2019 Apr 24;10:444
pubmed: 31105579
PLoS One. 2012;7(12):e52769
pubmed: 23300766
J Neurol Sci. 1988 Apr;84(2-3):275-94
pubmed: 3379447
Comp Med. 2006 Feb;56(1):17-22
pubmed: 16521855
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Front Pharmacol. 2018 Oct 26;9:1216
pubmed: 30416446
Transl Res. 2022 Jun;244:101-113
pubmed: 35114419
Front Endocrinol (Lausanne). 2022 May 25;13:893678
pubmed: 35692409
J Pharm Pharmacol. 2003 Mar;55(3):367-71
pubmed: 12724043
N Engl J Med. 1990 May 31;322(22):1561-6
pubmed: 2139921
Front Nutr. 2018 Dec 12;5:126
pubmed: 30619872
PLoS One. 2013;8(1):e52943
pubmed: 23341916
J Med Food. 2014 Jan;17(1):28-35
pubmed: 24456352
BMC Biol. 2015 Jul 22;13:50
pubmed: 26197889
Gait Posture. 2018 May;62:303-310
pubmed: 29609158
Ageing Res Rev. 2013 Sep;12(4):898-906
pubmed: 23948422
Trends Immunol. 2009 Jul;30(7):366-73
pubmed: 19540807
J Cachexia Sarcopenia Muscle. 2019 Dec;10(6):1195-1209
pubmed: 31313502
Clin Interv Aging. 2014 Mar 19;9:433-41
pubmed: 24672230
Sci Rep. 2016 Apr 11;6:24214
pubmed: 27064118
Physiol Rep. 2014 Feb 10;2(2):e00229
pubmed: 24744898
Methods Mol Biol. 2009;482:295-317
pubmed: 19089364
Neurochem Res. 2012 Apr;37(4):771-7
pubmed: 22179853
J Appl Physiol (1985). 2007 Jun;102(6):2389-97
pubmed: 17289908
Nat Commun. 2015 Apr 29;6:7035
pubmed: 25923845
Bone. 2013 Nov;57(1):206-19
pubmed: 23954506
J Clin Microbiol. 1985 Nov;22(5):870-2
pubmed: 2997273
Int J Mol Sci. 2016 Jan 13;17(1):
pubmed: 26771610
Nat Immunol. 2013 May;14(5):428-36
pubmed: 23598398
Biogerontology. 2013 Dec;14(6):729-39
pubmed: 24030242
Med Sci Sports Exerc. 1988 Apr;20(2):161-6
pubmed: 3367751
Evid Based Complement Alternat Med. 2019 Sep 02;2019:9590260
pubmed: 31565066
Wien Klin Wochenschr. 2017 Feb;129(3-4):81-95
pubmed: 27770207
Oxid Med Cell Longev. 2019 Apr 18;2019:1875471
pubmed: 31178951
Front Nutr. 2018 Sep 24;5:73
pubmed: 30320119
Am J Respir Cell Mol Biol. 2000 Jan;22(1):26-33
pubmed: 10615062
Age Ageing. 2017 May 1;46(3):383-392
pubmed: 28064173
Mayo Clin Proc. 1988 Jun;63(6):552-64
pubmed: 3374172
J Biol Chem. 2004 Mar 12;279(11):9777-84
pubmed: 14701853
J Vis Exp. 2015 Feb 06;(96):e52434
pubmed: 25742564
Aging (Milano). 2001 Feb;13(1):16-21
pubmed: 11292147
JAMA. 2011 Jan 5;305(1):50-8
pubmed: 21205966
Lancet. 2003 Feb 1;361(9355):393-5
pubmed: 12573379
J Am Med Dir Assoc. 2016 Mar 1;17(3):188-92
pubmed: 26805753
Proc Am Thorac Soc. 2009 Sep 15;6(6):527-31
pubmed: 19741262
J Nutr Sci Vitaminol (Tokyo). 2017;63(5):339-348
pubmed: 29225319
J Physiol. 2018 Apr 1;596(7):1199-1210
pubmed: 29344967
J Clin Invest. 2013 Feb;123(2):812-22
pubmed: 23298834
Sci Aging Knowledge Environ. 2006 May 03;2006(8):pe11
pubmed: 16672727
J Immunol Methods. 2018 Dec;463:21-26
pubmed: 30114401
J Nat Med. 2015 Oct;69(4):531-7
pubmed: 26014046
Neuropeptides. 2021 Dec;90:102199
pubmed: 34610544
Int J Chron Obstruct Pulmon Dis. 2020 Nov 27;15:3063-3077
pubmed: 33273811
Skelet Muscle. 2018 Aug 6;8(1):25
pubmed: 30081940
Proc Natl Acad Sci U S A. 2014 May 13;111(19):7090-5
pubmed: 24778222
Am J Cardiol. 1991 Aug 15;68(5):547-9
pubmed: 1872287
Sports Med. 2014 Nov;44 Suppl 2:S155-65
pubmed: 25355189
Int J Biomed Imaging. 2012;2012:734734
pubmed: 23197972
J Phys Ther Sci. 2016 Mar;28(3):794-801
pubmed: 27134360
J Am Soc Nephrol. 2015 Oct;26(10):2423-33
pubmed: 25644113
Curr Biol. 2015 Jun 1;25(11):1426-36
pubmed: 25959968
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):856-61
pubmed: 11792841
Ther Adv Urol. 2016 Feb;8(1):47-60
pubmed: 26834840
Nat Commun. 2018 Nov 19;9(1):4859
pubmed: 30451844
Immunol Rev. 2005 Jun;205:72-93
pubmed: 15882346
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Clin Invest. 2011 Nov;121(11):4393-408
pubmed: 21985788
Front Nutr. 2018 Oct 08;5:93
pubmed: 30349821
Acta Biochim Biophys Sin (Shanghai). 2014 Sep;46(9):738-48
pubmed: 25178463
Curr Pain Headache Rep. 2014 Oct;18(10):456
pubmed: 25160712
Geriatr Gerontol Int. 2017 Jan;17(1):54-60
pubmed: 26792269
Clin Sci (Lond). 2014 Sep;127(6):415-21
pubmed: 24708050
Nature. 1997 Nov 6;390(6655):45-51
pubmed: 9363890
Sci Rep. 2019 Oct 1;9(1):14103
pubmed: 31575929
Immunol Today. 1996 Jun;17(6):267-72
pubmed: 8962629
J Ethnopharmacol. 2020 Jan 10;246:112222
pubmed: 31505213
Mol Cell Biochem. 2011 Feb;348(1-2):89-98
pubmed: 21082218
Drugs Aging. 1995 Apr;6(4):301-11
pubmed: 7613019
PLoS One. 2015 Jan 24;10(1):e0116387
pubmed: 25617625
Neurosci Lett. 1999 Oct 1;273(2):93-6
pubmed: 10505624
Mech Ageing Dev. 2020 Jun;188:111244
pubmed: 32335099

Auteurs

Haruka Amitani (H)

Pharmacological Department of Herbal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Division of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Shigeki Chiba (S)

Kampo Research Laboratories, Kracie Pharma, Ltd., Tokyo, Japan.

Marie Amitani (M)

Education Center for Doctors in Remote Islands and Rural Areas, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Division of Community-Based Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Seiwa Michihara (S)

Kampo Research Laboratories, Kracie Pharma, Ltd., Tokyo, Japan.

Risa Takemoto (R)

Kampo Research Laboratories, Kracie Pharma, Ltd., Tokyo, Japan.

Likun Han (L)

Kampo Research Laboratories, Kracie Pharma, Ltd., Tokyo, Japan.

Nina Fujita (N)

Kampo Research Laboratories, Kracie Pharma, Ltd., Tokyo, Japan.

Ryuji Takahashi (R)

Kampo Research Laboratories, Kracie Pharma, Ltd., Tokyo, Japan.

Akio Inui (A)

Pharmacological Department of Herbal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Classifications MeSH